NovaBay Pharmaceuticals Rebrands to Stablecoin Development Corp After $134M Investment

NovaBay Pharmaceuticals has officially rebranded as Stablecoin Development Corporation, marking a complete strategic shift from healthcare to the digital asset sector. This transformation follows a substantial capital injection of $134 million from prominent investors, including Tether Investments and Framework Ventures. As part of its new focus, the company has acquired 2.06 billion SKY tokens and reported its initial staking rewards. The pivot highlights the company's commitment to stablecoin development and crypto asset management, backed by major industry players. Industry experts view this move as a significant fundamental change that signals a long-term commitment to the blockchain ecosystem. The rebranding and massive investment are expected to drive speculative interest and potentially increase the valuation of the company's stock and associated digital assets.

Sources:globenewswire.comtipranks.comgurufocus.comstocktitan.netainvest.com